Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy.

Blümer RM, van der Valk M, Ackermans M, Endert E, Serlie MJ, Reiss P, Sauerwein HP.

Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1097-104. doi: 10.1152/ajpendo.90988.2008. Epub 2009 Aug 18.

PMID:
19690066
[PubMed - indexed for MEDLINE]
Free Article
2.

The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).

Schindler K, Rieger A, Tura A, Gmeinhardt B, Touzeau-Römer V, Haider D, Pacini G, Ludvik B.

Horm Metab Res. 2009 Jul;41(7):573-9. doi: 10.1055/s-0029-1202779. Epub 2009 Mar 25.

PMID:
19322744
[PubMed - indexed for MEDLINE]
3.

Peroxisome proliferator-activated receptor gamma agonists and the treatment of HIV-associated lipoatrophy: unraveling the molecular mechanism of their shortcomings.

Hadigan C.

J Infect Dis. 2008 Dec 15;198(12):1729-31. doi: 10.1086/593180. No abstract available.

PMID:
18954262
[PubMed - indexed for MEDLINE]
Free Article
4.

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for Study of Diabetes.

Diabetes Care. 2009 Jan;32(1):193-203. doi: 10.2337/dc08-9025. Epub 2008 Oct 22.

PMID:
18945920
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Metformin increases HDL3-cholesterol and decreases subcutaneous truncal fat in nondiabetic patients with HIV-associated lipodystrophy.

Diehl LA, Fabris BA, Barbosa DS, De Faria EC, Wiechmann SL, Carrilho AJ.

AIDS Patient Care STDS. 2008 Oct;22(10):779-86. doi: 10.1089/apc.2008.0012.

PMID:
18800870
[PubMed - indexed for MEDLINE]
6.

Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).

Slama L, Lanoy E, Valantin MA, Bastard JP, Chermak A, Boutekatjirt A, William-Faltaos D, Billaud E, Molina JM, Capeau J, Costagliola D, Rozenbaum W.

Antivir Ther. 2008;13(1):67-76.

PMID:
18389900
[PubMed - indexed for MEDLINE]
7.

Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.

Salpeter SR, Buckley NS, Kahn JA, Salpeter EE.

Am J Med. 2008 Feb;121(2):149-157.e2. doi: 10.1016/j.amjmed.2007.09.016. Review.

PMID:
18261504
[PubMed - indexed for MEDLINE]
9.

Rosiglitazone : a review of its use in type 2 diabetes mellitus.

Deeks ED, Keam SJ.

Drugs. 2007;67(18):2747-79. Review.

PMID:
18062722
[PubMed - indexed for MEDLINE]
10.

Do current body mass index criteria for obesity surgery reflect cardiovascular risk?

Livingston EH, Chandalia M, Abate N.

Surg Obes Relat Dis. 2007 Nov-Dec;3(6):577-85. Epub 2007 Oct 23.

PMID:
17936086
[PubMed - indexed for MEDLINE]
11.

A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.

Kohli R, Shevitz A, Gorbach S, Wanke C.

HIV Med. 2007 Oct;8(7):420-6.

PMID:
17760733
[PubMed - indexed for MEDLINE]
12.

The management of dyslipidaemias in antiretroviral-treated HIV infection: a systematic review.

McGoldrick C, Leen CL.

HIV Med. 2007 Sep;8(6):325-34. Review.

PMID:
17661840
[PubMed - indexed for MEDLINE]
13.

Metformin and body weight.

Golay A.

Int J Obes (Lond). 2008 Jan;32(1):61-72. Epub 2007 Jul 24. Review.

PMID:
17653063
[PubMed - indexed for MEDLINE]
14.

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Nissen SE, Wolski K.

N Engl J Med. 2007 Jun 14;356(24):2457-71. Epub 2007 May 21. Erratum in: N Engl J Med. 2007 Jul 5;357(1):100..

PMID:
17517853
[PubMed - indexed for MEDLINE]
Free Article
15.

Long-term complications of antiretroviral therapy: lipoatrophy.

Waters L, Nelson M.

Int J Clin Pract. 2007 Jun;61(6):999-1014. Review.

PMID:
17504362
[PubMed - indexed for MEDLINE]
16.

A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.

Cavalcanti RB, Raboud J, Shen S, Kain KC, Cheung A, Walmsley S.

J Infect Dis. 2007 Jun 15;195(12):1754-61. Epub 2007 May 2.

PMID:
17492590
[PubMed - indexed for MEDLINE]
Free Article
17.

Class of antiretroviral drugs and the risk of myocardial infarction.

DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD.

N Engl J Med. 2007 Apr 26;356(17):1723-35.

PMID:
17460226
[PubMed - indexed for MEDLINE]
Free Article
18.

Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.

Haider DG, Schindler K, Mittermayer F, Müller M, Nowotny P, Rieger A, Luger A, Ludvik B, Wolzt M.

Clin Pharmacol Ther. 2007 Apr;81(4):580-5. Epub 2007 Jan 18. Erratum in: Clin Pharmacol Ther. 2007 Apr;81(4):611.

PMID:
17235334
[PubMed - indexed for MEDLINE]
19.

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.

Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Alston-Smith BL, Schouten JT, Fielding RA, Basar MT, Grinspoon S.

AIDS. 2007 Jan 2;21(1):47-57.

PMID:
17148967
[PubMed - indexed for MEDLINE]
20.

Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.

Bergersen BM.

Drugs. 2006;66(15):1971-87. Review.

PMID:
17100407
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk